Hermanns-Lê T
United Laboratories
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hermanns-Lê T.
Pediatric Dermatology | 2009
Géraldine Blaise; Arjen Nikkels; Pascale Quatresooz; Hermanns-Lê T; Gérald Pierard
Abstract:u2003 Cutaneous leiomyosarcoma is a soft tissue neoplasm exhibiting an aggressive local behavior and a potential for distant metastases. It is rare during childhood and diagnosis can be challenging both clinically and histologically. Surgical excision with wide lateral and deep margins is the treatment of choice, whereas radiotherapy and chemotherapy are contraindicated. Long‐term follow‐up is necessary as recurrences are not infrequent.
Archive | 2017
Claudine Pierard-Franchimont; Hermanns-Lê T; Gérald Pierard
Some specific chemical compounds called penetration enhancers breach the skin barrier function after topical applications. It is important to predict the severity of alteration of the skin permeability barrier function. Corneoxenometry was designed as an ex vivo bioassay predicting on human stratum corneum the efficacy and the potential noxious effects of xenobiotics. The test substrate is a cyanoacrylate skin surface stripping harvested from normal or altered skin. Dose-response effects are conveniently tested while avoiding any skin hazards.
Archive | 2015
Gérald Pierard; Hermanns-Lê T; Sébastien Pierard; Claudine Pierard-Franchimont
During perimenopause, the skin and a series of other organs become altered as prominent sex hormone declines. The natural climacteric is associated with a decline in functional properties of various tissues including viscoelasticity of the dermal connective tissue. There are many ways for assessing in vivo skin viscoelasticity, and the various procedures frequently measure distinct physical characteristics. The suction method has been selected by a majority of investigators looking at dermal functional changes during climacteric. Some women benefit from oral hormone replacement therapy (HRT) or transdermal estrogen therapy (TET) for controlling some unpleasant climacteric changes (osteoporosis, vasomotor instability, skin withering, dermal depletion in versican-hyaluronic acid, etc.). In particular, the hormonal repair exhibits some preventive and corrective effects in the functional decline of the dermal physical properties.
Revue médicale de Liège | 2012
Piérard Ge; Piérard-Franchimont C; Hermanns-Lê T; Philippe Delvenne
Revue médicale de Liège | 2012
Piérard-Franchimont C; Hermanns-Lê T; Marianne Lesuisse; Piérard Ge
Revue médicale de Liège | 2007
Piérard Ge; Piérard-Franchimont C; Hermanns-Lê T; Pascale Quatresooz
Archive | 2017
Gérald Pierard; Hermanns-Lê T; Claudine Pierard-Franchimont
International Journal of Clinical Rheumatology | 2016
Hermanns-Lê T; Gérald Pierard
Revue médicale de Liège | 2014
Piérard-Franchimont C; Piérard Ge; Philippe Delvenne; Hermanns-Lê T
Revue médicale de Liège | 2014
Piérard-Franchimont C; Hermanns-Lê T; Sébastien Pierard; Piérard Ge